That's helpful. And then just my follow-up around the EMEA region, you saw organic sales down about 2% there in the first quarter, understood that probably April is maybe trending worse than that based on Monish's comments. Maybe help us understand kind of are you seeing in EMEA exactly? Most companies seem to say it's about the same as it was a few months ago. Your sort of numbers and comments imply that you are seeing some kind of shorter cycle weakness there. Got you. And just a follow-up question. Interesting to note that you guys continue to push into electronics. You highlighted it as one of your sort of technologies within your periodic table. Reconciliations of the non-GAAP measures can be found in the attachments to today's press release. Please turn to Slide 3. Before I hand the call over to Mike, I would like to take a moment and highlight a financial reporting change we are making starting here in Q1 2022. We recognize that the increases in legal-related charges that we have incurred the past couple of years have impacted investors' understanding of our underlying financial and operating performance.

Ladies and gentlemen, thank you for standing by. Welcome to the 3M first quarter earnings conference call. [Operator instructions] As a reminder, this conference is being recorded, Tuesday, April 26, 2022. I would now like to turn the conference over to Bruce Jermeland, senior vice president of investor relations at 3M. I'm not sure I follow, Jeff. But you're asking, are we going to a go-forward basis? Yes. So we have made the adjustment that going forward, all costs for significant litigation matters will be shown as an adjustment to our earnings. And so you will see the GAAP EPS number, which is reported and adjusted earnings per share. A question for Monish, please. Just on the FX assumption for the year, 3M, historically, has been one of the few companies that actually use financial hedges on FX. Is this still in place? And there's typically a lag when you use those hedges, so -- versus what you're seeing in the spot market? Just what's -- I can see you've got that 1% to 2% in guidance, but are the hedges at play? Operator instructions] Our first question comes from Steve Tusa with J. P. Morgan Securities. You may proceed with your question.Thank you, Mike. And please turn to Slide 7. As a global manufacturer, 3M has a long record of environmental stewardship. Over the last two decades, we have reduced our greenhouse gas emissions by 75%, while more than doubling our revenue. No scissors or tape needed—just pull to expand, wrap in a 360° fashion around your item, tear by hand, then place into a box for a nested and protected ride. Understood. But it's not a sort of material headwind dialed in for Q2 or the balance of the year. You can sort of cope with it, the shortage still. At 3M, we are driven by purpose and powered by four industry-leading businesses, unique global capabilities and a highly experienced and diverse team. I am confident in our ability to grow above the macro and improve our operational performance as we move through 2022. I will now turn it over to John Banovetz. John?

Hopefully, I answered your question, Brendan, on item one. On your second item on operating cash flow, again, we have reiterated that we are -- and we started the year with 90% to 100% free cash flow conversion. We told you that at Investor Day, we reiterate. We have a path to get to the 90% to 100% free cash flow conversion. Yeah, Andrew. I would say you highlighted a couple of those particular challenges. The supply chain more broadly is impacting all of our businesses. So we're seeing disruptions in raw materials, logistics, inflation all that's impacting broadly our portfolio. Despite the current environment, the Health Care Business Group is focused on delivering clinically differentiated innovative platforms that improve patient outcomes and reduce cost of care. We have been sharply focused on three key segments: wound care; healthcare IT; and biopharma filtration. These segments are well supported by key market trends, which include: increasing chronic conditions driven by an aging population; shifting of care to lowest cost setting; improving healthcare access trends; and finally, digital and connected solutions. Please turn to Slide 15. Thank you, John. And I wish you all a very good morning. Please turn to Slide 9. The 3M team delivered strong execution in Q1 in a macro environment that remains extremely fluid and increasingly uncertain. Consumer did have organic growth up 3% in Q1 on top of 9% last year. And it was across all divisions. It was led by consumer health and safety also our home care and our home improvement products continue to lead the way. So we're seeing growth.Sure, Scott. Listen, the team did an amazing job. As I've talked about the tools that we've had, the daily management. Last year, we started slow on pricing, 0.14%, went up to 1.4% in Q3 and 2.6% and in Q4. Health care elective procedures still looking for there. And as Monish highlighted, the outlook for the macro in certain end markets is softening. That's less about supply chain disruptions. Maybe automotive and electronics being impacted by semiconductor shortages but its really more end market slowdowns that are impacting our businesses, where you see an impact on something like electronics or automotive.